alpha lipoic acid in burning mouth syndrome:a randomized double-blind placebo-controlled crossover trial

Phase 4

Completed

• Conditions: burning mouth syndrome; Neurological - Other neurological disorders

• Registration Number: ACTRN12608000251325
• Lead Sponsor: Fundacao de Amparo a Pesquisa do estado de sao paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-05-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

burning mouth for 6 months or more, absence of oral mucosal lesions, absence of sistemic conditions whose could produce burning mouth

Exclusion Criteria

oral burning under 6 months sistemic diseases (anemia and diabetes) oral mucosal diseases, hypossalivation

Study & Design

• Study Type: Interventional
• Study Design: Not specified